Synthesis, Characterization, and Evaluation of Antimicrobial Activity of Some 1,2,4-Triazole Derivatives Bearing an Antipyryl Moiety

Monatshefte fur Chemie

Volumn 134, Issue 3, 2003, Pages 465-474

  Ulusoy, Nuray ^a   Ateş, Öznur ^a   Küçükbasmaci, Ömer ^a   Kiraz, Muammer ^b   Yeǧenoǧlu, Yildiz ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

1,2,4 Triazoles; Antibacterial activity; Antifungal activity; Antimycobacterial activity; Antipyrines

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CANDIDA ALBICANS; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; CULTURE MEDIUM; DILUTION; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FLUORESCENCE; FRAGMENTATION REACTION; IN VITRO STUDY; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; RADIOMETRY; STAPHYLOCOCCUS AUREUS; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

EID: 0348231815     PISSN: 00269247     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00706-002-0546-z     Document Type: Article

References (39)

1. Modzelewska-Banachiewicz B, Matosiuk D (1999) Pharmazie 54: 588
2. Varvaresou A, Tsantili-Kakoulidou A, Siatra-Papastaikoudi T, Tiligada E (2000) Arzneim Forsch/Drug Res 50: 48
3. Küçükgüzel SG, Rollas S, Erdeniz H, Kiraz M (1999) Eur J Med Chem 34: 153
4. Holla BS, Gonsalves R, Shenoy S (2000) Eur J Med Chem 35: 267
5. Doǧan HN, Büyüktimkin S, Rollas S, Yemni E, Çevikbaş. A (1997) Farmaco 52: 565
6. Holla BS, Shivananda MK, Shenoy S, Antony G (1998) Boll Chim Farmac 137: 233
7. Hui X-P, Zhang L-M, Zhang Z-Y (1999) Indian J Chem, Sect B: Org Chem Incl Med Chem 38B: 1066
8. Mohan J, Kumar V (1998) Indian J Chem, Sect B: Org Chem Incl Med Chem 37B: 183
9. Doǧan HN, Rollas S, Erdeniz H (1998) Farmaco 53: 462
10. Ikizler AA, Johansson CB, Bekircan O, Çelik C (1999) Acta Pol Pharm 56: 283
11. Iqbal R, Rama NH, Ahmad N, Zamani K, Ebrahim S, Iqbal N (1998) Indian J Chem, Sect B: Org Chem Incl Med Chem 37B: 506
12. Papakonstantinou-Garoufalias SS, Todoulou OG, Filippatos EC, Papadaki-Valiraki AE, Chytiroglou-Lada A (1998) Arzneim-Forsch/Drug Res 48: 1019
13. Pandeya SN, Sriram D, Nath G, Clercq de E (2000) Arzneim Forsch/Drug Res 50: 55
14. Jalilian AR, Sattari S, Bineshmarvasti M, Shafiee A, Daneshtalab M (2000) Arch Pharm Pharm Med Chem 333: 347
15. Abdel-Ghani E (1997) Indian J Heterocycl Chem 7: 123
16. Marco F, Pfaller MA, Messer SA, Jones RN (1998) Med Mycol 36: 433
17. Wu Y, Qiao S, Liu C, Zhang D, Yang S, Zhou T (1998) Zhongguo Yaowu Huaxue Zazhi 8: 178
18. Ghannoum MA, Okogbule-Wonodi I, Bhat N, Sanati H (1999) J Chemother 11: 34
19. Macsaki S, Iwakawa J, Higashiyama Y, Miyazaki Y, Yanagihara K, Tomono K, Tashiro T, Kohno S (2000) J Infect Chemother 6: 101
20. Butters M, Ebbs J, Green SP, MacRae J, Morland MC, Murtiashaw CW, Pettman AJ (2001) Org Process Res Dev 5: 28
21. Pauw de BE (2000) Int J Antimicrob Agents 16: 147
22. Chen H-S, Li Z-M, Yang X-P, Wang H-G, Yao X-K (2000) Jiegou Huaxue 19: 317
23. Gülerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A (1997) Farmaco 52: 691
24. Udupi RH, Purushottamachar P (2000) Indian J Heterocycl Chem 9: 189
25. Udupi RH, Kushnoor A, Bhat AR (1999) J Indian Chem Soc 76: 461
26. Ergenç N, Ulusoy N, Ekinci AC (1995) Farmaco 50: 189
27. Ergenç N, Ulusoy N, Çapan G, Ötük Saniş G (1996) Arch Pharm Pharm Med Chem 329: 427
28. Ilhan E, Ergenç N, Ulusoy N, Ötük Saniş, G (1996) Pharmazie 51: 123
29. Ulusoy N, Çapan G, Ergenç N, Ekinci AC, Vidin A (1998) Acta Pharm Turc 40: 5
30. Günay NS, Çapan G, Ulusoy N, Ergenç N, Ötük G, Kaya D (1999) Farmaco 54: 826
31. Ateş Ö, Cesur N, Güner H, Uzun M, Kiraz M, Kaya D (1995) Farmaco 50: 361
32. Çapan G, Ergenç N, Ötük G (1990-92) J Fac Pharm Istanbul 26-28: 23
33. Cesur N, Ateş, Ö, Salman A, Uzun M, Kiraz M, Kasimoǧlu Ö, Kaya D (1994) Acta Pharm Turc 36: 74
34. th ed Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2000
35. th informational supplement (aerobic dilution) M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa, 2000
36. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa, 1997
37. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA (2000) J Clin Microbiol 38: 341
38. Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper C, Fothergill Jr, A, McGinnis MR, Menezes P, Messer SA, Nelson PW, Odds FC, Pasarell L, Peter J, Pfaller MA, Rex JH, Rinaldi MG, Shankland GS, Walsh TJ, Weitzman I (1997) J Clin Microbiol 35: 139
39. Collins LA, Franzblau SG (1997) Antimicrob Agents Chemother 41: 1004